For the readers interested in the stock health of Atossa Therapeutics Inc. (ATOS). It is currently valued at $2.90. When the transactions were called off in the previous session, Stock hit the highs of $3.00, after setting-off with the price of $2.41. Company’s stock value dipped to $2.41 during the trading on the day. When the trading was stopped its value was $2.36.
Recently in News on May 14, 2021, Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces financial results for the fiscal quarter ended March 31, 2021, and provides an update on recent company developments. You can read further details here
Atossa Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.90 on 02/04/21, with the lowest value was $0.88 for the same time period, recorded on 01/06/21.
Atossa Therapeutics Inc. (ATOS) full year performance was 63.84%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atossa Therapeutics Inc. shares are logging -42.91% during the 52-week period from high price, and 258.02% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.81 and $5.08.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 23991599 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Atossa Therapeutics Inc. (ATOS) recorded performance in the market was 205.26%, having the revenues showcasing -20.33% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 350.39M, as it employees total of 4 workers.
Atossa Therapeutics Inc. (ATOS) in the eye of market guru’s
During the last month, 1 analysts gave the Atossa Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.22, with a change in the price was noted +2.05. In a similar fashion, Atossa Therapeutics Inc. posted a movement of +241.34% for the period of last 100 days, recording 18,948,572 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATOS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Atossa Therapeutics Inc. (ATOS): Stocks Technical analysis and Trends
Raw Stochastic average of Atossa Therapeutics Inc. in the period of last 50 days is set at 66.98%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 88.75%. In the last 20 days, the company’s Stochastic %K was 68.33% and its Stochastic %D was recorded 67.29%.
If we look into the earlier routines of Atossa Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 205.26%. Additionally, trading for the stock in the period of the last six months notably improved by 104.23%, alongside a boost of 63.84% for the period of the last 12 months. The shares increased approximately by 5.84% in the 7-day charts and went down by 67.63% in the period of the last 30 days. Common stock shares were lifted by -20.33% during last recorded quarter.